Forside

Navamedic at a glance

  • Employees

    45

  • Revenue 2025 (MNOK)

    565.4

  • EBITDA 2025 (MNOK)

    47.6

  • Number of brands

    50

  • Countries where products are sold

    16

  • Established in

    2002

Financial Results

Take part of up-to-date financial results in our quarterly webcasts and reports.

View results

Enhanced Parkinson Care

Navamedic introduces a groundbreaking advancement in Parkinson’s care, enhancing precision and personalization in treatment. Our latest innovation aims to improve patient outcomes by addressing individual needs through simplified dosing.

 

Learn more